|
Restoring RUNX1 Levels in FPD/AML |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University |
The RUNX1 Research Program |
|
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models |
Icahn School of Medicine at Mount Sinai |
The RUNX1 Research Program |
|
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML |
Boston Children’s Hospital |
The RUNX1 Research Program |
|
Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome |
St. Jude Children’s Research Hospital |
Northwestern Mutual Foundation |
|
Enhancing Coping and Communication in Children with Cancer and Their Parents: A Novel Internet-Based Intervention |
Vanderbilt University Medical Center |
Northwestern Mutual Foundation |
|
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis |
Washington University |
Tap Cancer Out |
|
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
